ELAVL1 and metabolic dysfunction-associated steatotic liver disease: To delineate the hepatocyte-specific role of HuR in the NAFLD disease progression, HuRhKO mice were generated by tail-vein injection of HuRflox/flox mice with AAV8-TBGP-Cre recombinase and AAV8-TBGP-GFP was used as a control.